Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate targeting Isomesothelin; and ALEXIS-PRO-1, an allogeneic gamma delta chimeric T cell therapy product candidate targeting PD-L1. It has license agreements with CGA 369 Intellectual Holdings, Inc. and Longwood University, as well as a research and development collaboration agreement with Molipharma, S.R.L. The company also has strategic alliance agreement with Leon Office (H.K.) Ltd. The company was formerly known as Kiromic, Inc. and changed its name to Kiromic BioPharma, Inc. in December 2019. Kiromic BioPharma, Inc. was founded in 2006 and is headquartered in Houston, Texas. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Kiromic BioPharma Inc..
Kiromic BioPharma Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Kiromic BioPharma Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Kiromic BioPharma Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Kiromic BioPharma Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Kiromic BioPharma Inc. and all latest updates of the company are provided.
The 2025 version of Kiromic BioPharma Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Kiromic BioPharma Inc.- Key Facts
2.2 Kiromic BioPharma Inc.- Geographic Locations
2.3 Kiromic BioPharma Inc.- Subsidiaries and Affiliates
2.4 Kiromic BioPharma Inc.- Business Divisions
2.5 Kiromic BioPharma Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Kiromic BioPharma Inc. Strategic Analysis Review
3.1 Kiromic BioPharma Inc.- Key Strategies
3.2 Kiromic BioPharma Inc.- Company Outlook Statement
3.3 Kiromic BioPharma Inc.- SWOT Analysis
3.3.1 Kiromic BioPharma Inc.- Key Strengths
3.3.2 Kiromic BioPharma Inc.- Key Weaknesses
3.3.3 Kiromic BioPharma Inc.- Potential Opportunities
3.3.4 Kiromic BioPharma Inc.- Potential Threats
3.4 Kiromic BioPharma Inc.- Key Competitors
4. Business Description of the Company
4.1 Kiromic BioPharma Inc.- Business Overview
4.2 Kiromic BioPharma Inc.- Operations by Segment
5 Products and Services Details
5.1 Kiromic BioPharma Inc.- Key Products
5.2 Kiromic BioPharma Inc.- Key Service Areas
5.3 Kiromic BioPharma Inc.- Key Brands
6 Company Developments
6.1 Kiromic BioPharma Inc.- Company History
6.2 Kiromic BioPharma Inc.- Latest Developments
7 Financial Analysis
7.1 Kiromic BioPharma Inc.- Income Statements
7.2 Kiromic BioPharma Inc.- Balance Sheet
7.3 Kiromic BioPharma Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Kiromic BioPharma Inc.- Direct Competitors
8.2 Kiromic BioPharma Inc.- Competitor Financial Ratios comparison
8.3 Kiromic BioPharma Inc.- Competitor Stock Charts Comparison
8.4 Kiromic BioPharma Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!